Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Funder

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Endocrinology|November 8, 2003
Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase CAnastasia S Mihailidou, Mahidi Mardini, John W Funder
The Journal of Steroid Biochemistry and Molecular Biology|August 3, 2013
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptorsMichael E Baker, John W Funder, Stephanie R Kattoula
Trends in Endocrinology and Metabolism: TEM|April 6, 2005
Aldosterone as a cardiovascular risk factorGianPaolo Rossi, Marco Boscaro, Vanessa Ronconi, et al.
Endocrinology|February 24, 2011
Mineralocorticoid receptors: evolutionary and pathophysiological considerationsKarin S Kassahn, Mark A Ragan, John W Funder
Trends in Endocrinology and Metabolism: TEM|April 6, 2005
Low renin hypertensive states: perspectives, unsolved problems, future researchRichard D Gordon, John H Laragh, John W Funder
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at termFalguni A Patel, John W Funder, John R G Challis
Hypertension (Dallas, Tex. : 1979)|July 23, 2024
Comparing ARR Versus Suppressed PRA as Screening Tests for Primary AldosteronismMarco Marcelli, Caixia Bi, John W Funder, et al.
Endocrinology|February 15, 2003
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivationMorag J Young, Leon Moussa, Rod Dilley, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2002
Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemiaAnastasia S Mihailidou, Mahidi Mardini, John W Funder, et al.
Molecular and Cellular Endocrinology|May 12, 2004
Towards selectively modulating mineralocorticoid receptor function: lessons from other systemsJohn D Baxter, John W Funder, James W Apriletti, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Endocrinology|November 8, 2003
Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase CAnastasia S Mihailidou, Mahidi Mardini, John W Funder
The Journal of Steroid Biochemistry and Molecular Biology|August 3, 2013
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptorsMichael E Baker, John W Funder, Stephanie R Kattoula
Trends in Endocrinology and Metabolism: TEM|April 6, 2005
Aldosterone as a cardiovascular risk factorGianPaolo Rossi, Marco Boscaro, Vanessa Ronconi, et al.
Endocrinology|February 24, 2011
Mineralocorticoid receptors: evolutionary and pathophysiological considerationsKarin S Kassahn, Mark A Ragan, John W Funder
Trends in Endocrinology and Metabolism: TEM|April 6, 2005
Low renin hypertensive states: perspectives, unsolved problems, future researchRichard D Gordon, John H Laragh, John W Funder
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at termFalguni A Patel, John W Funder, John R G Challis
Hypertension (Dallas, Tex. : 1979)|July 23, 2024
Comparing ARR Versus Suppressed PRA as Screening Tests for Primary AldosteronismMarco Marcelli, Caixia Bi, John W Funder, et al.
Endocrinology|February 15, 2003
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivationMorag J Young, Leon Moussa, Rod Dilley, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2002
Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemiaAnastasia S Mihailidou, Mahidi Mardini, John W Funder, et al.
Molecular and Cellular Endocrinology|May 12, 2004
Towards selectively modulating mineralocorticoid receptor function: lessons from other systemsJohn D Baxter, John W Funder, James W Apriletti, et al.
Pageof 14